Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.600
+0.050 (3.23%)
At close: Aug 13, 2025, 4:00 PM
1.610
+0.010 (0.63%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $49.38 million as of August 14, 2025. Its market cap has decreased by -55.88% in one year.
Market Cap
49.38M
Enterprise Value
49.07M
1-Year Change
-55.88%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $49.38M, a decrease of -76.18%. That is a compound annual growth rate of -61.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 49.38M | -59.72% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 593.49B |
| Johnson & Johnson | 419.85B |
| AbbVie | 356.30B |
| UnitedHealth Group | 246.00B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.39B |